Oct 072020
Talent4Boards - Great Talent builds Great Boards
– SWITZERLAND, Zurich – Inositec, a pioneer in the development of life-saving small molecule drugs for calcification disorders such as aortic valve stenosis, today announced the appointment of Dr. Michael Davidson, MD to its Board of Directors. Dr. Davidson is CEO of New Amsterdam Pharma and was previously founding CEO and ...
Inositec appoints Dr. Michael Davidson to its Board of Directors
Inositec appoints Dr. Michael Davidson to its Board of Directors
From:: Inositec appoints Dr. Michael Davidson to its Board of Directors
Sorry, the comment form is closed at this time.